EARNINGS: Litigation Capital interim loss widens; Aurora UK NAV rises
1st Apr 2026 14:25
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 10.30p on 03-04-2026 at 04:45:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 10.50p |
| Sell | 9.00p |
| Last Trade: | Buy 40,000.00 at 10.30p |
| Day's Volume: | 0 |
| Last Close: | 10.30p |
| Open: | 0.00p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 5.25p - 12.10p |
| Market Capitalisation: | £652.25m |
| VWAP: | 0.00p |
| Shares in Issue: | 6.33b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 40,000 | 10.30p | Suspected BUY Trade |
16:35:29 - 02-Apr-26 |
| Buy* | 10,000 | 10.50p | Suspected BUY Trade |
14:00:13 - 02-Apr-26 |
| Buy* | 400 | 10.38p | Ordinary |
13:48:08 - 02-Apr-26 |
| Buy* | 1 | 10.38p | Ordinary |
13:12:18 - 02-Apr-26 |
| Buy* | 1,145 | 9.85p | Ordinary |
11:05:23 - 02-Apr-26 |
| Buy* | 7,000 | 10.50p | Suspected BUY Trade |
11:00:08 - 02-Apr-26 |
| Buy* | 6,000 | 10.50p | Suspected BUY Trade |
09:00:29 - 02-Apr-26 |
| Buy* | 6,800 | 10.50p | Suspected BUY Trade |
08:00:00 - 02-Apr-26 |
| Buy* | 35,000 | 10.30p | Ordinary |
16:36:01 - 01-Apr-26 |
| Buy* | 35,000 | 10.30p | Suspected BUY Trade |
16:35:22 - 01-Apr-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 31st Mar 2026 7:00 am | RNS | Interim Results for six months ended 31 Dec 2025 |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 4th Mar 2026 7:00 am | RNS | Positive Biomarker Results from PROTECT Trial |
| 26th Feb 2026 7:00 am | RNS-R | Allergy Therapeutics presents progress at AAAAI |
| 23rd Feb 2026 7:51 am | RNS | Update on funding and total voting rights |
| 30th Jan 2026 8:22 am | RNS | Chief Strategy Officer and Board appointments |
| 29th Jan 2026 2:13 pm | RNS | Result of Annual General Meeting |
| 28th Jan 2026 4:48 pm | RNS | Grant of Options under Long Term Incentive Scheme |
| 19th Jan 2026 7:00 am | RNS | Half Year Trading Update |